Anti-oxidant vitamin e prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice

  • M. Nieborowska-Skorska
  • , G. Hoser
  • , A. Hochhaus
  • , T. Stoklosa
  • , T. Skorski

Research output: Contribution to journalLetterpeer-review

10 Scopus citations
Original languageEnglish
Pages (from-to)2253-2254
Number of pages2
JournalLeukemia
Volume27
Issue number11
DOIs
StatePublished - Nov 2013

Keywords

  • Animals
  • Antineoplastic Agents/adverse effects
  • Antioxidants/therapeutic use
  • Benzamides/adverse effects
  • Drug Resistance, Neoplasm/drug effects
  • Fusion Proteins, bcr-abl/genetics
  • Humans
  • Imatinib Mesylate
  • Interleukin Receptor Common gamma Subunit/physiology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Mutation/genetics
  • Piperazines/adverse effects
  • Pyrimidines/adverse effects
  • Vitamin E/therapeutic use

Fingerprint

Dive into the research topics of 'Anti-oxidant vitamin e prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice'. Together they form a unique fingerprint.

Cite this